Qube Research & Technologies Ltd - LARIMAR THERAPEUTICS INC ownership

LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 70 filers reported holding LARIMAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$207,392
+27.2%
45,782
+311.6%
0.00%
-66.7%
Q1 2021$163,000
-82.3%
11,123
-74.1%
0.00%
-76.9%
Q4 2020$919,000
+60.9%
42,923
+14.0%
0.01%
+62.5%
Q3 2020$571,00037,6450.01%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
CHI Advisors LLC 3,414,468$8,720,3832.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 16,941,357$53,026,4471.13%
Opaleye Management Inc. 1,390,000$4,350,7001.04%
DAFNA Capital Management LLC 350,373$1,096,6670.30%
MANGROVE PARTNERS IM, LLC 805,815$2,522,2010.18%
Atlas Venture Advisors, Inc. 292,184$914,5360.16%
Verition Fund Management LLC 2,716,713$8,503,3120.11%
Woodline Partners LP 1,681,913$5,264,3880.06%
Fi3 FINANCIAL ADVISORS, LLC 25,548$79,9650.04%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 363,505$1,137,7710.04%
View complete list of LARIMAR THERAPEUTICS INC shareholders